Got $2,000: Invest in These 2 Cheap TSX Stocks to Double Your Money

Despite their near-term risks, both BlackBerry and Canopy Growth offer strong long-term growth potential.

| More on:
Money growing in soil , Business success concept.

Image source: Getty Images

The Canadian financial markets have recovered strongly from their March lows. However, some of the stocks are still struggling and are trading at attractive valuations. So, if you have the appetite for risk-taking and can stay invested for extended periods, I believe these two stocks could deliver huge profits.

BlackBerry

When the majority of the tech companies have delivered excellent returns this year, BlackBerry (TSX:BB)(NYSE:BB) is struggling with its stock, trading over 24% lower. The company’s significant exposure to the automotive industry impacted its financials in its recently completed first quarter.

Its adjusted revenue declined by 19.9% on a year-over-year basis. The global auto production shutdowns and project delays amid the pandemic had dragged the company’s revenue down. However, with the reopening of the economies, the auto sector is beginning to recover.

The company also provides cybersecurity solutions for companies across various sectors. With the rise in the number of employees working from their homes, the demand for data safety and privacy solutions has increased, which could benefit BlackBerry.

At the end of its first quarter, the company’s cash, cash equivalents, and investments stood at US$955 million. Further, the company’s management expects its free cash flow to be positive for this fiscal year. So, the company’s liquidity position looks secure. Given its attractive valuation, strong balance sheet, and growth prospects, I believe investors with a long-term horizon should buy the stock for higher gains.

Canopy Growth

My second pick is a cannabis company Canopy Growth (TSX:WEED)(NYSE:CGC), which has lost over 20% of its stock value this year. Although the cannabis sector is facing structural issues, the company had outperformed analysts’ sales expectations in its recently reported first-quarter results.

Its revenues came in at $110.4 million against analysts’ expectations of $93.5 million. The growth in medical sales offset the decline in recreational sales to drive the company’s revenue. The increased competition and the temporary closure of retail stores due to the pandemic dragged the company’s recreational sales down.

However, Canopy Growth has re-positioned its value brand Tweed dried flower with higher and more consistent THC ranges and is working on expanding its Cannabis 2.0 offerings in Canada to drive its recreational sales. In the United States, the company has increased its online presence by launching an e-commerce site, which sells all brands of CBD products from Canopy growth.

The company has also scaled up the distribution of its S&B vaporizer and BioSteel RTD non-CBD beverages to some of the key markets in the United States. All these initiatives could drive the company’s top line.

Meanwhile, its adjusted EBITDA is still in negative territory, which is a cause of concern. The company is working on lowering its expenditures. Year to date, the company has reduced its headcount by 18%. Further, it has optimized its production by closing two of its facilities in British Columbia and one indoor facility in Saskatchewan. Along with these cost-cutting initiatives, the growth in higher-margin Cannabis 2.0 product sales could aid the company in attaining profitability.

Moreover, in its first quarter, the company reduced its cash burn by 50% to $180.1 million. At the end of the quarter, the company’s gross cash stood at $2 billion. So, given its strong growth potential, improving margins, and strong balance sheet, I believe Canopy Growth’s stock could double over the next three years.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends BlackBerry and BlackBerry. Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »